Sign in
4

Changes in Ownership

BioAge Labs, Inc. Filed Acc 0001415889-25-004859

Options or other derivatives

  • Chief Financial Officer acquired 170,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
GOLDSTEIN DOV A MD Chief Financial Officer 2025-02-18 Grant or award · Stock Option (Right to Buy) +170,000 170,000 D: show line 1 in the form
Loading xslF345X05/form4-02202025_090258.xml…